(相关资料图)
杰富瑞将Nurix Therapeutics的目标价从41美元上调至45美元,维持“买入”评级。(格隆汇)
2026-06-09
2026-06-08
2026-06-07
2026-06-06
2026-06-05
2026-06-04
2026-06-03
2026-06-02
2026-06-01